Springer Nature
Browse

sorry, we can't preview this file

40364_2023_511_MOESM9_ESM.eps (1.32 MB)

Additional file 9 of Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxel

Download (1.32 MB)
figure
posted on 2023-07-26, 03:22 authored by Jessica D. Lang, Tuong Vi V. Nguyen, Maren K. Levin, Page E. Blas, Heather L. Williams, Esther San Roman Rodriguez, Natalia Briones, Claudius Mueller, William Selleck, Sarah Moore, Victoria L. Zismann, William P.D. Hendricks, Virginia Espina, Joyce O’Shaughnessy
Supplementary Material 9

Funding

Takeda Oncology Baylor Scott and White Dallas Foundation

History

Usage metrics

    Biomarker Research

    Categories

    Keywords

    Triple-negative breast cancerTargeted therapyCell signalingGenomicsProteomics

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC